Concepedia

Jeffrey W. Raggon

JW

Statistics

Publications

12

Citations

496

H-Index

11

Active since

1982

Affiliations

Pfizer (United States)(Current)

Jeffrey W. Raggon is an author at Pfizer (United States) specializing in chemistry, medicinal chemistry, and organic chemistry.

Publications per year

1982–2018

12

Publications

12

Discovery of Two Clinical Histamine H <sub>3</sub> Receptor Antagonists: <i>trans</i> - <i>N</i> -Ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and <i>trans</i> -3-Fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]- <i>N</i> -(2-methylpropyl)cyclobutanecarboxamide (PF-03654764)

Travis T. Wager, Betty Pettersen, Anne W. Schmidt et al. · Journal of Medicinal Chemistry · 2011 · 108 citations · Full text

, , +16

Cross-Coupling Methods for the Large-Scale Preparation of an Imidazole−Thienopyridine:  Synthesis of [2-(3-Methyl-3H-imidazol-4-yl)- thieno[3,2-<i>b</i>]pyridin-7-yl]-(2-methyl-1H-indol-5-yl)-amine

John A. Ragan, Jeffrey W. Raggon, Paul D. Hill et al. · Organic Process Research & Development · 2003 · 60 citations

, , +13

Furan-Terminated <i>N</i>-Acyliminium Ion Initiated Cyclizations in Alkaloid Synthesis

Steven P. Tanis, Melissa V. Deaton, Lisa A. Dixon et al. · The Journal of Organic Chemistry · 1998 · 52 citations

, , +17

Pharmaceutical impurity identification: A case study using a multidisciplinary approach

Karen M. Alsante, Peter Boutros, Michel Couturier et al. · Journal of Pharmaceutical Sciences · 2004 · 50 citations

, , +14

Streamlined Processes for the Synthesis of a Farnesyl Transferase Inhibitor Drug Candidate

Brian M. Andresen, Michel Couturier, Brian J. Cronin et al. · Organic Process Research & Development · 2004 · 39 citations

, , +12

1–5 of 12